Heart valve inserted in trial via catheter.A team of Michigan cardiac surgeons said they inserted an Edwards Lifesciences Edwards Lifesciences (NYSE: EW) is a global leader in products and technologies to treat advanced cardiovascular disease, the global leader in acute hemodynamic monitoring and the number-one heart valve company in the world. Corp. valve into the first American First American may refer to:
The development is considered a critical phase for a product that officials at the Irvine-based company hope will play a key role in future heart surgeries. The valve, inserted via a catheter rather than an open-heart procedure, came from Edwards' 2004 purchase last year of Percutaneous Valve Technologies Inc. for $125 million. Edwards was given the OK to launch the Cribier-Edwards trial earlier this year after wrestling with regulators over the trial's design, and facing some criticism about its efficacy. Surgeons at William Beaumont Hospital This article is about William Beaumont Hospital, Michigan. For for the hospital in Dublin, see Beaumont Hospital, Dublin. William Beaumont Hospital is a regional medical system in the greater Detroit, Michigan area. in Royal Oak, Mich., said they inserted a Cribier-Edwards replacement aortic aortic pertaining to or emanating from the aorta. See also aortic arch. aortic aneurysm occurs most often in dogs, where it is caused by Spirocerca lupi larvae, turkeys and primates, causing dyspnea, cyanosis and coughing. heart valve into a 76-year-old man. They used a cardiac catheter cardiac catheter n. A long, fine catheter that can be passed into the chambers of the heart via a vein or artery as a means of withdrawing samples of blood, measuring pressures within the heart's chambers or great vessels, or injecting contrast media. instead of opening his chest and stopping his heart, as in traditional open-heart surgery for valve implants. Dr. William O'Neill, the trial's principal investigator, said in a release that the procedure "may offer hope to seriously ill, high-risk patients who are not candidates for traditional open-heart surgery." The Percutaneous deal marked Edwards entry into the market for less-invasive valves. Edwards is the leading maker of valves implanted during open-heart surgery, with about a third of the market. There had been speculation that less-invasive heart valves Heart valves Valves that regulate blood flow into and out of the heart chambers. Mentioned in: Heart Failure could take business from Edwards. --Orange County Business Journal |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion